INSIDE INDUSTRY
Abstract
BAYER HealthCare and Economic Development Board to foster translational and clinical research for diseases prevalent in Asia
Ludwig Cancer Research and University of Oxford launch Cancer Immunotherapy Spinout
OmniComm Systems® Announces Reseller Agreement with Tri-I Biotech Shanghai Inc. Market Leading Life Sciences Consultancy to Resell OmniComm’s TrialOne® eSource Solution
Resverlogix Closes License Agreement and Enters Into Definitive Stock Purchase Agreement with Hepalink
Immunovaccine and PharmAthene Sign Exclusive Worldwide License Agreement to Develop and Commercialize an Anthrax Vaccine Formulated in DepoVax™
Commonwealth Financing Authority Announces New Alternative, Clean Energy Investment
ContraFect Corporation Announces Issuance of Key Patent Covering Novel Lysin Technology
M Pharmaceutical Inc. Rebrands Itself to Better Reflect Growing Family of Biomedical Technologies
Sustainable Apparel Coalition Recognizes SCS Global Services as Approved Verifier for New Pilot Program
StemCell United Announces Plans for PO and Listing on ASX
Roche Diagnostics Strengthens Footprint in Asia Pacific
- Bayer
- EDB
- Economic Development Board
- Clinical Research
- Ludwig Cancer Research
- University of Oxford
- Spinout
- Cancer Immunotherapy
- Reseller
- OmniComm
- Biotech Shanghai
- Resverlogix
- Immunovaccine
- PharmAthene
- License agreement
- DepoVax
- Commonwealth
- Anthrax vaccine
- vaccine
- Clean Energy investment
- energy
- Lysin Technology
- ContraFect
- Rebrands
- Biomedical Technologies
- M Pharmaceutical
- Sustainable
- Apparel
- PO
- IPO
- StemCell United
- Roche Diagnostics
- Roche
